Editors' note: Blood NfL: A biomarker for disease severity and progression in Parkinson disease

被引：0
|
作者：
Galetta, Steven
机构：
来源：
NEUROLOGY | 2020年 / 95卷 / 14期
关键词：
D O I：
10.1212/WNL.0000000000010663
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：657 / 657
页数：1
相关论文
共 50 条
  • [1] Blood NfL A biomarker for disease severity and progression in Parkinson disease
    Lin, Chin-Hsien
    Li, Cheng-Hsuan
    Yang, Kai-Chien
    Lin, Fang-Ju
    Wu, Chau-Chung
    Chieh, Jen-Jie
    Chiu, Ming-Jang
    NEUROLOGY, 2019, 93 (11) : E1104 - E1111
  • [2] Author response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease
    Lin, Chin-Hsien
    Chiu, Ming-Jang
    NEUROLOGY, 2020, 95 (14) : 658 - 658
  • [3] Reader response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease
    van Rumund, Anouke
    Marques, Taina M.
    Esselink, Rianne A. J.
    Bloem, Bastiaan R.
    Verbeek, Marcel M.
    NEUROLOGY, 2020, 95 (14) : 657 - 658
  • [4] Divining progression in Parkinson disease with a blood test NfL
    Boylan, Laura S.
    Chio, Adriano
    NEUROLOGY, 2019, 93 (11) : 471 - 472
  • [5] Blood transcriptomic biomarker of disease progression in Parkinson's Disease
    Lee, R.
    Seok, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S736 - S736
  • [6] NfL as a biomarker for neurodegeneration and survival in Parkinson disease
    Backstrom, David
    Linder, Jan
    Mo, Susanna Jakobson
    Riklund, Katrine
    Zetterberg, Henrik
    Blennow, Kaj
    Forsgren, Lars
    Lenfeldt, Niklas
    NEUROLOGY, 2020, 95 (07) : E827 - E838
  • [7] Gut Microbiota Dysbiosis in Parkinson's Disease Patients: A Potential Biomarker of Disease Severity and Progression?
    Cerroni, R.
    Conti, M.
    Pierantozzi, M.
    D'Angelo, V.
    Mercuri, N.
    Teofani, A.
    Pietrucci, D.
    Chillemi, G.
    Unida, V.
    Stefani, A.
    MOVEMENT DISORDERS, 2023, 38 : S183 - S184
  • [8] Blood microRNA-7 as a Progression Biomarker in Parkinson's disease
    Doursout, M.
    Adams, C.
    Suescun, J.
    Block, K.
    Tharp, E.
    Ellmore, T.
    Schiess, M.
    MOVEMENT DISORDERS, 2022, 37 : S584 - S584
  • [9] Dyspnea in Parkinson's disease: A biomarker of disease's severity?
    Baille, G.
    Perez, T.
    Machuron, F.
    Defebvre, L.
    Chenivesse, C.
    Moreau, C.
    MOVEMENT DISORDERS, 2018, 33 : S766 - S766
  • [10] Parkinson Disease-Associated Polyneuropathy: A Biomarker of Disease Severity?
    Rosso, M.
    Merola, A.
    Romagnolo, A.
    Comi, C.
    Fasano, A.
    Zibetti, M.
    Lopez-Castellanos, R.
    Cocito, D.
    Lopiano, L.
    Espay, A.
    MOVEMENT DISORDERS, 2017, 32
12345